The New York Times reports on how Kinsa, a startup company that sells internet-connected thermometers, uses its “illness data” to support partnerships with health companies. Clorox paid to license Kinsa’s information, enabling the company to target communities struck by fevers with products useful in combating illness. The article also points to how Amazon was recently granted a patent to recommend certain products to users who display symptoms, such as coughing or sniffling. While Kinsa appears to be operating in a privacy-compliant fashion, Electronic Privacy Information Center Consumer Protection Counsel Christine Bannan, CIPP/US, warns this further supports the need for federal legislation on how consumer data is handled. (Registration may be required to access this story.)
If you want to comment on this post, you need to login.